1,230 results on '"Klocker, Helmut"'
Search Results
2. Cholinergic signaling via muscarinic M1 receptor confers resistance to docetaxel in prostate cancer
3. STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway
4. The Oncogenic Protein Kinase/ATPase RIOK1 Is Up-Regulated via the c-myc/E2F Transcription Factor Axis in Prostate Cancer
5. Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
6. Emerging promising biomarkers for treatment decision in metastatic castration-resistant prostate cancer
7. Glycoprofiling of proteins as prostate cancer biomarkers: A multinational population study
8. Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer
9. Nanoparticle-Based Bio-Barcode Assay Redefines “Undetectable” PSA and Biochemical Recurrence after Radical Prostatectomy*
10. Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression
11. Dual role of allele-specific DNA hypermethylation within the TERT promoter in cancer
12. Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts
13. Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis
14. Figure S1 from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
15. Table S1 from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
16. Suppl Figure legends from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
17. Supplementary Tables 1-2, Supplementary Figures 1-2 from Genetic Variation of Genes Involved in Dihydrotestosterone Metabolism and the Risk of Prostate Cancer
18. Supplementary Figure S1 from hTERT-Immortalized Prostate Epithelial and Stromal-Derived Cells: an Authentic In vitro Model for Differentiation and Carcinogenesis
19. Supplementary Materials & Methods from hTERT-Immortalized Prostate Epithelial and Stromal-Derived Cells: an Authentic In vitro Model for Differentiation and Carcinogenesis
20. Data from Circulating Tumor-Specific DNA: A Marker for Monitoring Efficacy of Adjuvant Therapy in Cancer Patients
21. Data from Identification of a Novel Prostate Tumor Target, Mindin/RG-1, for Antibody-Based Radiotherapy of Prostate Cancer
22. Data from hTERT-Immortalized Prostate Epithelial and Stromal-Derived Cells: an Authentic In vitro Model for Differentiation and Carcinogenesis
23. Color version of Fig. 3 from Identification of a Novel Prostate Tumor Target, Mindin/RG-1, for Antibody-Based Radiotherapy of Prostate Cancer
24. Supplementary Figure Legend from hTERT-Immortalized Prostate Epithelial and Stromal-Derived Cells: an Authentic In vitro Model for Differentiation and Carcinogenesis
25. Supplementary Tables 1-3 from Circulating Tumor-Specific DNA: A Marker for Monitoring Efficacy of Adjuvant Therapy in Cancer Patients
26. The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer
27. Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer
28. Androgen Receptor Function in Prostate Cancer Progression
29. Low Cycle Fatigue of G20Mn5 Cast Steel Relation between Microstructure and Fatigue Life
30. Finite Elements Analysis of LED's Solder Joints During Power Thermal Cycling
31. STAT3 restricts prostate cancer metastasis and antiandrogen resistance by controlling LKB1/CREB signaling pathway
32. Attenuation of nucleoside and anti-cancer nucleoside analog drug uptake in prostate cancer cells by Cimicifuga racemosa extract BNO-1055
33. Novel therapeutic approaches for the treatment of castration-resistant prostate cancer
34. MALDI-MS tissue imaging identification of biliverdin reductase B overexpression in prostate cancer
35. Prostaglandin E2 induces stromal cell-derived factor-1 expression in prostate stromal cells by activating protein kinase A and transcription factor Sp1
36. Increased accuracy of a novel mRNA‐based urine test for bladder cancer surveillance
37. Fibroblast Growth Factors and Their Receptors in Metastases of Prostate and Other Urological Cancers
38. Die Bedeutung der systemischen Glukokortikoid Begleitmedikation auf die stromale Glukokortikoidrezeptor-Aktivität und Auswirkungen auf das Prostatatumor Wachstum
39. Estradiol promotes epithelial‐to‐mesenchymal transition in human benign prostatic epithelial cells
40. Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
41. Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot
42. Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk
43. High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity
44. PIAS1 Is Increased in Human Prostate Cancer and Enhances Proliferation through Inhibition of p21
45. Abstract 3183: Targeting a myofibroblastic prostate cancer-associated fibroblast subtype through pharmacological inhibition of NADPH oxidase 4
46. Nanoparticle-Based Bio-Barcode Assay Redefines "Undetectable" PSA and Biochemical Recurrence after Radical Prostatectomy
47. Expression of the IGF Axis Is Decreased in Local Prostate Cancer but Enhanced after Benign Prostate Epithelial Differentiation and TGF-β Treatment
48. Plexin-B1 Mutations in Prostate Cancer
49. Effects of cycling and rowing on serum concentrations of prostate‐specific antigen: A randomized study of 101 male subjects
50. Additional file 5 of Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.